Herbal Medicine Formulation Research Group, Korea Institute of Oriental Medicine, 483 Expo-ro, Daejeon 305-811, Yusung-gu, Republic of Korea.
BMC Complement Altern Med. 2014 Jul 1;14:215. doi: 10.1186/1472-6882-14-215.
Guibi-Tang is a traditional herbal prescription made from 12 different herbs that is used in the treatment of amnesia and poor memory.
In the present study, we evaluated the acute oral toxicity and genotoxic potential of Guibi-Tang water extract (GBT) at doses up to 2000 μg/plate an using a bacterial reverse mutation test (Ames test) with Salmonella typhimurium strains TA100, TA1535, TA98, and TA1537, and Escherichia coli strain WP2uvrA. Acute toxicity and genotoxic potential were measured in the presence and absence of an exogenous source of metabolic activation, in an in vitro chromosome aberration assay with Chinese hamster lung (CHL) cells, and in an in vivo micronucleus test using ICR mice bone marrow as recommended by the Korean Food and Drug Administration. An acute oral toxicity test of GBT was performed in Sprague Dawley rats. The Ames test showed that GBT did not induce gene mutations in S. typhimurium or in E. coli in the presence or absence of S9 activation.
GBT did not significantly increase the number of structural aberrations in CHL cells with or without S9 activation. The oral administration of GBT at a dose of up to 2000 mg/kg caused no significant increase in the number of micronucleated polychromatic erythrocytes or in the mean ratio of polychromatic to total erythrocytes.
However, as we did not identify the components of GBT responsible for these effects, other assays are needed to confirm its genotoxicity.
龟鳖汤是一种由 12 种不同草药制成的传统草药配方,用于治疗健忘症和记忆力减退。
在本研究中,我们使用沙门氏菌 typhimurium 菌株 TA100、TA1535、TA98 和 TA1537 和大肠杆菌 WP2uvrA 进行了细菌回复突变试验(Ames 试验),评估了龟鳖汤水提取物(GBT)的急性口服毒性和遗传毒性潜力,剂量高达 2000μg/平板。在存在和不存在外源性代谢激活物的情况下,在体外中国仓鼠肺(CHL)细胞染色体畸变试验中和在 ICR 小鼠骨髓体内微核试验中测量了急性毒性和遗传毒性潜力,这是韩国食品和药物管理局推荐的方法。对 GBT 的急性口服毒性试验在 Sprague Dawley 大鼠中进行。Ames 试验表明,在存在或不存在 S9 激活的情况下,GBT 不会诱导 S. typhimurium 或大肠杆菌中的基因突变。
GBT 不会在有或没有 S9 激活的情况下显着增加 CHL 细胞的结构畸变数量。在高达 2000mg/kg 的剂量下口服给予 GBT 不会导致微核多染红细胞数量或多染红细胞与总红细胞的平均比值显着增加。
然而,由于我们没有确定 GBT 中导致这些效应的成分,因此需要进行其他试验来确认其遗传毒性。